D.E. Shaw & Co’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-103,422
| Closed | -$2.09M | – | 4377 |
|
|
2021
Q3 | $2.09M | Buy |
+103,422
| New | +$2.09M | ﹤0.01% | 2076 |
|
|
2021
Q2 | – | Sell |
-27,090
| Closed | -$693K | – | 3877 |
|
|
2021
Q1 | $693K | Sell |
27,090
-88,755
| -77% | -$2.27M | ﹤0.01% | 2366 |
|
|
2020
Q4 | $2.55M | Sell |
115,845
-15,078
| -12% | -$332K | ﹤0.01% | 1632 |
|
|
2020
Q3 | $2.36M | Sell |
130,923
-20,894
| -14% | -$376K | ﹤0.01% | 1557 |
|
|
2020
Q2 | $3.86M | Sell |
151,817
-9,032
| -6% | -$229K | ﹤0.01% | 1295 |
|
|
2020
Q1 | $2.96M | Buy |
160,849
+41,579
| +35% | +$764K | ﹤0.01% | 1323 |
|
|
2019
Q4 | $2.63M | Buy |
119,270
+97,733
| +454% | +$2.15M | ﹤0.01% | 1487 |
|
|
2019
Q3 | $309K | Buy |
+21,537
| New | +$309K | ﹤0.01% | 2263 |
|
|
2017
Q1 | – | Sell |
-12,257
| Closed | -$35K | – | 2676 |
|
|
2016
Q4 | $35K | Sell |
12,257
-40,083
| -77% | -$114K | ﹤0.01% | 2454 |
|
|
2016
Q3 | $308K | Sell |
52,340
-22,451
| -30% | -$132K | ﹤0.01% | 2195 |
|
|
2016
Q2 | $224K | Buy |
74,791
+35,316
| +89% | +$106K | ﹤0.01% | 2349 |
|
|
2016
Q1 | $212K | Buy |
39,475
+15,481
| +65% | +$83.1K | ﹤0.01% | 2374 |
|
|
2015
Q4 | $285K | Buy |
+23,994
| New | +$285K | ﹤0.01% | 2300 |
|
|
2015
Q2 | – | Sell |
-14,978
| Closed | -$360K | – | 2774 |
|
|
2015
Q1 | $360K | Sell |
14,978
-6,680
| -31% | -$161K | ﹤0.01% | 2193 |
|
|
2014
Q4 | $357K | Buy |
+21,658
| New | +$357K | ﹤0.01% | 2143 |
|
|
2014
Q2 | – | Sell |
-25,809
| Closed | -$729K | – | 2642 |
|
|
2014
Q1 | $729K | Buy |
+25,809
| New | +$729K | ﹤0.01% | 1712 |
|